DuP 105
CAS No. 96800-41-8
DuP 105 ( —— )
Catalog No. M26183 CAS No. 96800-41-8
DuP 105 is an orally active oxazolidinone, a new class of synthetic antimicrobial agent with activity against gram-positive bacteria.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 1791 | Get Quote |
|
10MG | 2412 | Get Quote |
|
25MG | 3582 | Get Quote |
|
50MG | 4842 | Get Quote |
|
100MG | 6534 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDuP 105
-
NoteResearch use only, not for human use.
-
Brief DescriptionDuP 105 is an orally active oxazolidinone, a new class of synthetic antimicrobial agent with activity against gram-positive bacteria.
-
DescriptionDuP 105 is an orally active oxazolidinone, a new class of synthetic antimicrobial agent with activity against gram-positive bacteria.(In Vitro):DuP 105 MICs for 50% of the 216 gram-positive isolates tested (MIC50s) range from 4.0 to 16 μg/mL.DuP 105 shows inhibitory activities against staphylococcal isolates and B. fragilis isolates with MIC90s of 4 to 16 μg/mL and 16 μg/mL.(In Vivo):DuP 105 administered by either the oral or the parenteral route is protective against staphylococcal and streptococcal infections in mice with the 50% effective doses of 9 to 23 mg/kg.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number96800-41-8
-
Formula Weight296.3
-
Molecular FormulaC13H16N2O4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(cc1)S(C)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nanda JS, Lorsch JR. Labeling a protein with fluorophores using NHS ester derivitization. Methods Enzymol. 2014;536:87-94.
molnova catalog
related products
-
Curculigoside
Curculigoside can prevent bone loss , improve osteogenesis and inhibit osteoclastogenesis of hAFSCs, suggesting its potential use to regulate hAFSC osteogenic differentiation for treating bone disorders.
-
Roniacol
3-Pyridinemethanol is a useful synthetic intermediate.
-
Perflexane
Perflexane was developed as an ultrasound contrast agent.